Clinical trial

Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept

NCT02095418

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Mycophenolate mofetil, Corticosteroids Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Corticosteroids, Mycophenolate mofetil Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-02-01

PhaseNA

Conditions

Diabetesverified · MONDO: diabetes mellitus

Interventions

Mycophenolate mofetil, CorticosteroidsDRUG

Corticosteroids, Mycophenolate mofetilDRUG

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Mapped research locations

SeoulSouth Korea3 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02095418 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.